Top Markets
Coin of the day
Clover Biopharmaceuticals, Ltd. Clover Biopharmaceuticals, Ltd.

Clover Biopharmaceuticals, Ltd.

2197
Classificação em ações #15712
Clover Biopharmaceuticals, Ltd. is a biotechnology enterprise focused on... Clover Biopharmaceuticals, Ltd. is a biotechnology enterprise focused on discovering, developing, and commercializing innovative vaccines and biological therapies. Their efforts target infectious diseases, various cancers, and autoimmune conditions. The company's pipeline features several key candidates: SCB-2019 (CpG 1018/Alum): A COVID-19 vaccine candidate currently advancing through Phase II/III clinical trials. SCB-313: A trimeric fusion protein aimed at treating severe intracavitary malignancies, including malignant ascites, malignant pleural effusions, and peritoneal carcinomatosis, addressing a significant global medical need. SCB-808: Undergoing pivotal Phase III clinical trials for the management of rheumatic disorders. SCB-420: An aflibercept biosimilar in preclinical development for ophthalmologic conditions like wet age-related macular degeneration. SCB-219: A novel TPOR agonist in preclinical stages for the treatment of chemotherapy-induced thrombocytopenia and immune thrombocytopenic purpura. Clover also holds a collaboration and supply agreement with Dynavax, which provides its CpG 1018 adjuvant for use in preclinical studies. The company was established in 2007 and is based in Shanghai, China.
Preço da ação
$0.25841098
Valor de mercado
$335.38M
Variação (1 dia)
-2.42%
Variação (1 ano)
73.70%
País
CN
Negociar Clover Biopharmaceuticals, Ltd. (2197)

Categoria

Histórico de preços das ações de Clover Biopharmaceuticals, Ltd. (2197)
Preço de fecho mais alto: $0.26 em 2026-09-01

Preço de fecho mais baixo: $1.43 em 2021-11-01
Histórico de preços das ações da Clover Biopharmaceuticals, Ltd. de 2021 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) -11.59%
2025 858.49%
2024 -56.65%
2023 -82.45%
2022 -72.65%
2021 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$549.03 40.41%
US
$1.02K 43.76%
NL
$147.18 510.96%
US
$121.37 -11.93%
AU
$748.60 4.92%
CH